ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 14 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,612,000 | -79.7% | 2,750,000 | -78.0% | 0.01% | -87.5% |
| Q3 2020 | $7,950,000 | -8.4% | 12,500,000 | 0.0% | 0.10% | -31.9% |
| Q2 2020 | $8,679,000 | +8.2% | 12,500,000 | -13.8% | 0.14% | -1.4% |
| Q1 2020 | $8,023,000 | -29.2% | 14,500,000 | 0.0% | 0.14% | +6.7% |
| Q4 2019 | $11,325,000 | -3.2% | 14,500,000 | 0.0% | 0.13% | -15.2% |
| Q3 2019 | $11,698,000 | -4.6% | 14,500,000 | 0.0% | 0.16% | -15.5% |
| Q2 2019 | $12,265,000 | – | 14,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |